US Patent 11959080 Methods and compositions for inhibiting PMP22 expression
Patent 11959080 was granted and assigned to Ionis Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11959080 Methods and compositions for inhibiting PMP22 expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.